Valiant Laboratories Statistics
Total Valuation
NSE:VALIANTLAB has a market cap or net worth of INR 4.21 billion. The enterprise value is 4.34 billion.
| Market Cap | 4.21B |
| Enterprise Value | 4.34B |
Important Dates
The last earnings date was Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:VALIANTLAB has 54.31 million shares outstanding. The number of shares has increased by 47.47% in one year.
| Current Share Class | 54.31M |
| Shares Outstanding | 54.31M |
| Shares Change (YoY) | +47.47% |
| Shares Change (QoQ) | +1.25% |
| Owned by Insiders (%) | 29.86% |
| Owned by Institutions (%) | 1.01% |
| Float | 12.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.77 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 67.87, with an EV/FCF ratio of -9.72.
| EV / Earnings | -132.70 |
| EV / Sales | 1.83 |
| EV / EBITDA | 67.87 |
| EV / EBIT | n/a |
| EV / FCF | -9.72 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.91 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 7.23 |
| Debt / FCF | -1.04 |
| Interest Coverage | 0.18 |
Financial Efficiency
Return on equity (ROE) is -1.20% and return on invested capital (ROIC) is -0.47%.
| Return on Equity (ROE) | -1.20% |
| Return on Assets (ROA) | 0.05% |
| Return on Invested Capital (ROIC) | -0.47% |
| Return on Capital Employed (ROCE) | 0.10% |
| Weighted Average Cost of Capital (WACC) | 6.85% |
| Revenue Per Employee | 30.06M |
| Profits Per Employee | -413,658 |
| Employee Count | 79 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 7.98 |
Taxes
In the past 12 months, NSE:VALIANTLAB has paid 40.36 million in taxes.
| Income Tax | 40.36M |
| Effective Tax Rate | 525.40% |
Stock Price Statistics
The stock price has decreased by -25.38% in the last 52 weeks. The beta is 0.96, so NSE:VALIANTLAB's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -25.38% |
| 50-Day Moving Average | 68.21 |
| 200-Day Moving Average | 72.64 |
| Relative Strength Index (RSI) | 56.06 |
| Average Volume (20 Days) | 19,809 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:VALIANTLAB had revenue of INR 2.37 billion and -32.68 million in losses. Loss per share was -0.51.
| Revenue | 2.37B |
| Gross Profit | 403.04M |
| Operating Income | 3.50M |
| Pretax Income | 7.68M |
| Net Income | -32.68M |
| EBITDA | 63.90M |
| EBIT | 3.50M |
| Loss Per Share | -0.51 |
Balance Sheet
The company has 331.50 million in cash and 462.12 million in debt, with a net cash position of -130.62 million or -2.41 per share.
| Cash & Cash Equivalents | 331.50M |
| Total Debt | 462.12M |
| Net Cash | -130.62M |
| Net Cash Per Share | -2.41 |
| Equity (Book Value) | 3.11B |
| Book Value Per Share | 56.57 |
| Working Capital | 1.09B |
Cash Flow
In the last 12 months, operating cash flow was -104.32 million and capital expenditures -342.00 million, giving a free cash flow of -446.32 million.
| Operating Cash Flow | -104.32M |
| Capital Expenditures | -342.00M |
| Depreciation & Amortization | 60.40M |
| Net Borrowing | -762.56M |
| Free Cash Flow | -446.32M |
| FCF Per Share | -8.22 |
Margins
Gross margin is 16.97%, with operating and profit margins of 0.15% and -1.38%.
| Gross Margin | 16.97% |
| Operating Margin | 0.15% |
| Pretax Margin | 0.32% |
| Profit Margin | -1.38% |
| EBITDA Margin | 2.69% |
| EBIT Margin | 0.15% |
| FCF Margin | n/a |
Dividends & Yields
NSE:VALIANTLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.47% |
| Shareholder Yield | -47.47% |
| Earnings Yield | -0.78% |
| FCF Yield | -10.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |